BioNTech SE (/biːˈɒntɛk/ bee-ON-tek; or /baɪˈɒntɛk/ bye-ON-tek short for Biopharmaceutical New Technologies) is a German biotechnology company based in... 40 KB (3,633 words) - 02:16, 24 March 2024 |
and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19 vaccine ($11 billion in 2023 revenues), apixaban ($6 billion in... 170 KB (14,795 words) - 18:05, 9 May 2024 |
Operation Warp Speed (section Pfizer–BioNTech) development and production capacity of the Pfizer–BioNTech COVID-19 vaccine. On November 9, the Pfizer–BioNTech partnership announced positive early results... 71 KB (5,902 words) - 12:57, 30 April 2024 |
the genomic DNA. While some messenger RNA vaccines, such as the Pfizer–BioNTech COVID-19 vaccine, have the disadvantage of requiring ultracold storage... 78 KB (7,926 words) - 15:19, 26 April 2024 |
Uğur Şahin (category BioNTech) is a German oncologist and immunologist. He is the founder and CEO of BioNTech, which developed one of the major vaccines against COVID-19. His main fields... 56 KB (6,113 words) - 09:37, 1 May 2024 |
weakened immune systems. Several COVID‑19 vaccines, such as the Pfizer–BioNTech and Moderna vaccines, use RNA to stimulate an immune response. When introduced... 192 KB (22,024 words) - 10:32, 9 May 2024 |